Longitudinal Assessment of DNA Damage in PBMCs From Hospitalized COVID ‐19 Patients via Alkaline Comet Assay
Environmental and Molecular Mutagenesis · 2026-03 · 67 (3)
DOI: 10.1002/em.70055 ↗At a glance
Journal article in Environmental and Molecular Mutagenesis, published online on 2026-04-24. Written by Lenin Rueda-Torres and 4 co-authors. Institution: Instituto Nacional de Salud, Centro Nacional de Salud Ocupacional y Protección del Ambiente Para la Salud, Lima, Perú. Major MEDLINE topics: DNA Damage, Leukocytes, Mononuclear, COVID-19. 56 references. Funded by: Instituto Nacional de Salud.
Abstract (original language)
Growing evidence suggests an association between SARS‐CoV‐2 infection and oxidative stress–related genomic damage, primarily from cross‐sectional studies. However, longitudinal evaluations remain limited. Here, we assessed DNA damage in peripheral blood mononuclear cells (PBMCs) from hospitalized COVID‐19 patients during the first days of hospitalization, using the alkaline comet assay. A longitudinal descriptive study was conducted at a modular COVID‐19 hospital in Lima, Peru, throughout October 2020. Blood samples were collected at admission (day 0), day 3, and day 6. DNA damage was assessed by measuring tail length, tail moment, and tail intensity, which were modeled using mixed‐effects linear models. Concurrent hematological parameters and acute‐phase proteins were also analyzed to characterize their time‐course patterns in conjunction with DNA damage. Results from the adjusted mixed‐effects model showed a significant temporal increase in DNA damage parameters, particularly tail intensity ( β = 0.25 per day, p = 0.003), relative to baseline measurements, with a peak observed on day 3 of hospitalization. These changes aligned with variations in platelet counts and transferrin levels, while lymphocyte and monocyte counts, along with C‐reactive protein, showed an inverse trend, reflecting the dynamic interplay of the inflammatory response and DNA damage. No significant differences in comet assay parameters were observed between survivors and non‐survivors, likely due to the limited and unbalanced sample. The findings indicate the presence of a measurable DNA damage burden in PBMCs of hospitalized COVID‐19 patients, highlighting the need to further studies to clarify the mechanisms underlying DNA damage and its potential long‐term biological implications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Instituto Nacional de Salud, Centro Nacional de Salud Ocupacional y Protección del Ambiente Para la Salud, Lima, Perú.
- University College London, Institute of Health Informatics, London, UK.
- Universidad Peruana Cayetano Heredia, Lima, Peru.
- Instituto Nacional de Salud, Dirección de Investigación e Innovación en Salud, Lima, Peru.
ORCID profiles: Lenin Rueda-Torres, Dulce E Alarcón-Yaquetto, Beatriz Ayala-Quintanilla, Germán Málaga, Jaime Rosales-Rimache
Funding
- Instituto Nacional de Salud
Cite
APA
Rueda-Torres, L., Alarcón-Yaquetto, D. E., Ayala-Quintanilla, B., Málaga, G., & Rosales-Rimache, J. (2026). Longitudinal Assessment of DNA Damage in PBMCs From Hospitalized COVID ‐19 Patients via Alkaline Comet Assay. Environmental and Molecular Mutagenesis, 67(3). https://doi.org/10.1002/em.70055
Vancouver
Rueda-Torres L, Alarcón-Yaquetto DE, Ayala-Quintanilla B, Málaga G, Rosales-Rimache J. Longitudinal Assessment of DNA Damage in PBMCs From Hospitalized COVID ‐19 Patients via Alkaline Comet Assay. Environmental and Molecular Mutagenesis. 2026;67(3). doi:10.1002/em.70055
BibTeX
@article{RuedaTorres2026,
author = {Rueda-Torres, Lenin and Alarcón-Yaquetto, Dulce E and Ayala-Quintanilla, Beatriz and Málaga, Germán and Rosales-Rimache, Jaime},
title = {Longitudinal Assessment of DNA Damage in PBMCs From Hospitalized COVID ‐19 Patients via Alkaline Comet Assay},
journal = {Environmental and Molecular Mutagenesis},
year = {2026},
volume = {67},
number = {3},
doi = {10.1002/em.70055}
}
EUVIMED